HOMEPRODUCTSSERVICESCOMPANYCONTACTFAQResearchDictionaryPharmaMobileSign Up FREE or Login

modipafant

structure given in first source ; PAF antagonist
Also Known As:
4-(2-chlorophenyl)-6-methyl-2-(4-(2-methylimidazo(4,5-c)pyrid-1-yl)phenyl)-5-(2-pyridinylcarbamoyl)-1,4-dihydropyridine-3-carboxylic acid ethyl ester; UK 74505; UK 80067; UK-74505; UK-80067; 3-Pyridinecarboxylic acid, 4-(2-chlorophenyl)-1,4-dihydro-6-methyl-2-(4-(2-methyl-1H-imidazo(4,5-c)pyridin-1-yl)phenyl)-5-((2-pyridinylamino)carbonyl)-, ethyl ester
Networked: 4 relevant articles (0 outcomes, 2 trials/studies)

Bio-Agent Context: Research Results

Experts

1. Pinho, Vanessa: 2 articles (06/2003 - 03/2002)
2. Shimizu, Takao: 2 articles (06/2003 - 03/2002)
3. Ishii, Satoshi: 2 articles (06/2003 - 03/2002)
4. Teixeira, Mauro M: 2 articles (06/2003 - 03/2002)
5. Souza, Danielle G: 1 article (06/2003)
6. Soares, Adriana C: 1 article (06/2003)
7. Alessandrini, Ana Letícia: 1 article (03/2002)
8. Klein, André: 1 article (03/2002)

Related Diseases

1. Reperfusion Injury
2. Ischemia
3. Asthma (Bronchial Asthma)
4. Pleurisy (Pleuritis)
5. Inflammation

Related Drugs and Biologics

1. Antigens
2. platelet activating factor receptor
3. Platelet Activating Factor